ACM Research (ACMR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
22 May, 2026Technology and product innovation
Differentiated semiconductor equipment technology enhances yields and reduces chemical use, supported by over 594 patents globally as of 12/31/25.
Broad product portfolio includes cleaning, ECP, furnace, PECVD, track, and advanced packaging tools, covering over 90% of cleaning process steps.
Recent launches include Ultra Pmax PECVD, Ultra Track Coater/Developer, and advanced panel-level packaging tools.
ACM Planetary Family product structure introduced, organizing offerings into series for cleaning, plating, furnace, PECVD, and packaging.
Continuous innovation with major performance breakthroughs and new product evaluations underway.
Financial performance and growth
Achieved $231.3M revenue in Q1 2026, up 34.2% year-over-year, with total shipments of $240.7M.
Maintained strong gross margins: 46.4% GAAP and 46.5% non-GAAP in Q1 2026.
Q1 2026 GAAP operating income was $36.2M (15.6% of revenue); non-GAAP operating income was $41.8M (18.1% of revenue).
Five-year revenue CAGR of 42%, with FY25 revenue reaching $901M and a diversified product mix.
Long-term internal target set for $4B+ in annual revenue, driven by expansion in China and international markets.
Market and customer base
Supplies leading global semiconductor manufacturers, with a balanced customer mix across memory, foundry/logic, and packaging.
Largest customer accounted for 16.9% of 2025 revenue; top four customers made up 52.2%.
Revenue mix shifting, with cleaning at 53%, ECP/furnace/other at 36%, and advanced packaging/other at 11% in Q1 2026.
Estimated 2025 serviceable available market (SAM) of $21B, with significant opportunities in cleaning, PECVD, track, and advanced packaging.
Global footprint includes facilities in the US, China, Korea, and Europe, with new Oregon production center to support reshoring and growth.
Latest events from ACM Research
- Q1 2026 revenue rose 34.2% to $231.3M, with strong ECP growth and $110M raised from share sale.ACMR
Q1 20268 May 2026 - Shareholders will vote virtually on director elections, auditor ratification, and strong governance practices.ACMR
Proxy filing27 Apr 2026 - 2025 revenue rose 15.2% to $901.3M, with expanding global reach and product innovation.ACMR
Investor presentation20 Mar 2026 - 2025 revenue hit $901.3M, with 2026 guidance for 21–30% growth despite margin pressure.ACMR
Q4 202526 Feb 2026 - Q2 revenue up 40% to $202.5M, margins strong, 2024 guidance raised, new products launched.ACMR
Q2 20242 Feb 2026 - Q3 revenue up 21% to $204M, margins strong, 2024 outlook raised, global expansion ongoing.ACMR
Q3 202416 Jan 2026 - Supply chain localization and product innovation drive growth amid export controls and market shifts.ACMR
UBS Global Technology and AI Conference11 Jan 2026 - 2024 revenue rose 40% to $782.1M, with strong margins and a robust 2025 outlook.ACMR
Q4 202423 Dec 2025 - Shareholders will elect four directors and ratify the auditor at a virtual 2025 annual meeting.ACMR
Proxy Filing1 Dec 2025